95 related articles for article (PubMed ID: 8868142)
21. Procoagulant albumin increases vascular endothelial cell prostacyclin secretion.
Gubler DB; Ahlstrom CR; Liu L; Zhou JF; Parker CJ; Rodgers GM
Thromb Haemost; 1995 Dec; 74(6):1573-7. PubMed ID: 8772239
[TBL] [Abstract][Full Text] [Related]
22. Function of tissue-type plasminogen activator releaser on vascular endothelial cells and thrombolysis in vivo.
Ueshima S; Matsuno H; Hayashi M; Horibuchi K; Okada K; Fukao H; Uematsu T; Matsuo O
Thromb Haemost; 2002 Jun; 87(6):1069-74. PubMed ID: 12083488
[TBL] [Abstract][Full Text] [Related]
23. Plasminogen-dependent and -independent proteolytic activity of murine endothelioma cells with targeted inactivation of fibrinolytic genes.
Lijnen HR; Wagner EF; Collen D
Thromb Haemost; 1997 Feb; 77(2):362-7. PubMed ID: 9157597
[TBL] [Abstract][Full Text] [Related]
24. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system.
Lijnen HR; Silence J; Lemmens G; Frederix L; Collen D
Thromb Haemost; 1998 Jun; 79(6):1171-6. PubMed ID: 9657444
[TBL] [Abstract][Full Text] [Related]
25. Biology of the endothelium.
Lüscher TF; Barton M
Clin Cardiol; 1997 Nov; 20(11 Suppl 2):II-3-10. PubMed ID: 9422846
[TBL] [Abstract][Full Text] [Related]
26. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC
Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of vascular endothelial cell prostacyclin synthesis by plasmin.
Schafer AI; Rodriguez R; Loscalzo J; Gimbrone MA
Blood; 1989 Aug; 74(3):1015-20. PubMed ID: 2526669
[TBL] [Abstract][Full Text] [Related]
28. Role of the endothelium in the vascular effects of the thrombin receptor (protease-activated receptor type 1) in humans.
Gudmundsdóttir IJ; Lang NN; Boon NA; Ludlam CA; Webb DJ; Fox KA; Newby DE
J Am Coll Cardiol; 2008 May; 51(18):1749-56. PubMed ID: 18452780
[TBL] [Abstract][Full Text] [Related]
29. Role of nitric oxide and prostacyclin as vasoactive hormones released by the endothelium.
Mitchell JA; Ali F; Bailey L; Moreno L; Harrington LS
Exp Physiol; 2008 Jan; 93(1):141-7. PubMed ID: 17965142
[TBL] [Abstract][Full Text] [Related]
30. Coagulation and endothelial dysfunction during longterm hyperdynamic porcine bacteremia--effects of selective inducible nitric oxide synthase inhibition.
Matejovic M; Krouzecky A; Radej J; Rokyta R; Kralova H; Radermacher P; Novak I
Thromb Haemost; 2007 Feb; 97(2):304-9. PubMed ID: 17264961
[TBL] [Abstract][Full Text] [Related]
31. Platelets and endothelial cells act in concert to delay thrombolysis--evidence from an in vitro model of the human occlusive thrombus.
Hantgan RR; Jerome WG; Handt S
Thromb Haemost; 1998 Mar; 79(3):602-8. PubMed ID: 9531049
[TBL] [Abstract][Full Text] [Related]
32. Secretion of tissue plasminogen activator and plasminogen activator inhibitor 1 during cardiopulmonary bypass.
Chandler WL; Velan T
Thromb Res; 2003; 112(3):185-92. PubMed ID: 14967416
[TBL] [Abstract][Full Text] [Related]
33. Modulation of sympathetic activity by tissue plasminogen activator is independent of plasminogen and urokinase.
Schaefer U; Vorlova S; Machida T; Melchor JP; Strickland S; Levi R
J Pharmacol Exp Ther; 2007 Jul; 322(1):265-73. PubMed ID: 17429057
[TBL] [Abstract][Full Text] [Related]
34. Role of astrocyte-derived tissue-type plasminogen activator in the regulation of endotoxin-stimulated nitric oxide production by microglial cells.
Vincent VA; Löwik CW; Verheijen JH; de Bart AC; Tilders FJ; Van Dam AM
Glia; 1998 Feb; 22(2):130-7. PubMed ID: 9537833
[TBL] [Abstract][Full Text] [Related]
35. B1 kinin receptor does not contribute to vascular tone or tissue plasminogen activator release in the peripheral circulation of patients with heart failure.
Cruden NL; Tse GH; Fox KA; Ludlam CA; Megson I; Newby DE
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):772-7. PubMed ID: 15681300
[TBL] [Abstract][Full Text] [Related]
36. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
[TBL] [Abstract][Full Text] [Related]
37. Secretory function of vascular endothelium and its implication in the action of vasoactive drugs.
Gryglewski RJ
Pol J Pharmacol Pharm; 1990; 42(3):219-36. PubMed ID: 2263533
[TBL] [Abstract][Full Text] [Related]
38. Prostacyclin in hypertension.
Frölich JC
J Hypertens Suppl; 1990 Sep; 8(4):S73-8. PubMed ID: 2258788
[TBL] [Abstract][Full Text] [Related]
39. A paradox of thrombogenesis by streptokinase and its prevention by iloprost and camonagrel.
Korbut R; Gryglewski RJ
Methods Find Exp Clin Pharmacol; 1996 Apr; 18(3):167-74. PubMed ID: 8738067
[TBL] [Abstract][Full Text] [Related]
40. Platelet-vessel wall interactions, focal adhesions, and the mechanism of action of endothelial factors.
Walter U; Geiger J; Haffner C; Markert T; Nehls C; Silber RE; Schanzenbächer P
Agents Actions Suppl; 1995; 45():255-68. PubMed ID: 7717187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
